Jim Simons’s Dr. Reddy's Laboratories RDY Stock Holding History

Jim Simons’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$109M	Sell	7,859,728 -395,400	-5%	-$5.5M	0.17%	135
2025 Q4	$116M	Sell	8,255,128 -527,500	-6%	-$7.4M	0.18%	122
2025 Q3	$123M	Sell	8,782,628 -230,500	-3%	-$3.32M	0.16%	123
2025 Q2	$135M	Sell	9,013,128 -182,100	-2%	-$2.6M	0.18%	107
2025 Q1	$121M	Sell	9,195,228 -223,200	-2%	-$3.08M	0.18%	106
2024 Q4	$149M	Sell	9,418,428 -333,817	-3%	-$5.01M	0.22%	87
2024 Q3	$155M	Sell	9,752,245 -225,230	-2%	-$3.62M	0.23%	80
2024 Q2	$152M	Buy	9,977,475 +328,030	+3%	+$4.7M	0.26%	70
2024 Q1	$142M	Buy	9,649,445 +345,470	+4%	+$5.04M	0.22%	83
2023 Q4	$129M	Buy	9,303,975 +126,855	+1%	+$1.7M	0.2%	95
2023 Q3	$123M	Buy	9,177,120 +941,000	+11%	+$12.7M	0.21%	99
2023 Q2	$104M	Sell	8,236,120 -138,000	-2%	-$1.61M	0.15%	144
2023 Q1	$95.3M	Buy	8,374,120 +50,500	+0.6%	+$545K	0.13%	187
2022 Q4	$86.1M	Sell	8,323,620 -545,570	-6%	-$5.89M	0.12%	183
2022 Q3	$92.8M	Sell	8,869,190 -1,319,500	-13%	-$14.1M	0.13%	167
2022 Q2	$113M	Buy	10,188,690 +627,500	+7%	+$6.82M	0.13%	169
2022 Q1	$107M	Sell	9,561,190 -12,500	-0.1%	-$142K	0.13%	170
2021 Q4	$125M	Sell	9,573,690 -368,000	-4%	-$4.64M	0.16%	139
2021 Q3	$130M	Sell	9,941,690 -84,000	-0.8%	-$1.12M	0.17%	118
2021 Q2	$147M	Sell	10,025,690 -160,000	-2%	-$2.24M	0.18%	94
2021 Q1	$125M	Sell	10,185,690 -1,070,500	-10%	-$13.8M	0.16%	128
2020 Q4	$160M	Sell	11,256,190 -555,500	-5%	-$7.48M	0.17%	108
2020 Q3	$164M	Buy	11,811,690 +52,000	+0.4%	+$620K	0.16%	114
2020 Q2	$125M	Buy	11,759,690 +1,784,450	+18%	+$18.2M	0.11%	191
2020 Q1	$80.5M	Buy	9,975,240 +1,430,830	+17%	+$11.9M	0.08%	263
2019 Q4	$69.3M	Buy	8,544,410 +1,152,000	+16%	+$9.1M	0.05%	397
2019 Q3	$56M	Buy	7,392,410 +1,399,410	+23%	+$10.4M	0.05%	468
2019 Q2	$44.9M	Buy	5,993,000 +673,000	+13%	+$5.29M	0.04%	543
2019 Q1	$43.1M	Buy	5,320,000 +243,000	+5%	+$1.85M	0.04%	581
2018 Q4	$38.3M	Buy	5,077,000 +1,160,500	+30%	+$8.16M	0.04%	541
2018 Q3	$27.1M	Buy	3,916,500 +1,047,450	+37%	+$7M	0.03%	739
2018 Q2	$18.5M	Buy	2,869,050 +2,787,050	+3,399%	+$17.6M	0.02%	970
2018 Q1	$536K	Buy	+82,000	New	+$575K	﹤0.01%	2891
2017 Q4	–	Sell	-509,000	Closed	-$3.63M	–	3481
2017 Q3	$3.63M	Sell	509,000 -914,500	-64%	-$6.58M	﹤0.01%	1953
2017 Q2	$12M	Buy	1,423,500 +872,385	+158%	+$7.09M	0.02%	1158
2017 Q1	$4.42M	Buy	+551,115	New	+$4.76M	0.01%	1761
2016 Q3	–	Sell	-661,500	Closed	-$6.78M	–	3465
2016 Q2	$6.78M	Buy	661,500 +540,000	+444%	+$4.95M	0.01%	1409
2016 Q1	$1.1M	Sell	121,500 -232,000	-66%	-$2.07M	﹤0.01%	2546
2015 Q4	$3.27M	Sell	353,500 -232,500	-40%	-$2.55M	0.01%	1768
2015 Q3	$7.49M	Sell	586,000 -234,500	-29%	-$2.91M	0.02%	1109
2015 Q2	$9.08M	Buy	820,500 +800,500	+4,003%	+$8.84M	0.02%	1032
2015 Q1	$228K	Buy	+20,000	New	+$212K	﹤0.01%	2844
2013 Q4	–	Sell	-421,000	Closed	-$3.18M	–	2994
2013 Q3	$3.18M	Buy	+421,000	New	+$3.06M	0.01%	1418

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Jim Simons's RDY Position: Q1 2026 in Review

Jim Simons reduced its Dr. Reddy's Laboratories (RDY) stake by 4.8% in Q1 2026, selling an estimated $5.5M and leaving 7,859,728 shares worth $109M. The position accounts for 0.17% of the portfolio, ranked #135.

Jim Simons first reported a position in RDY in Q3 2013 and has held it in 43 quarters since. The position peaked at $164M in Q3 2020. 248 funds tracked by Wall St. Rank hold RDY as of Q1 2026.

Jim Simons held 7,859,728 shares of Dr. Reddy's Laboratories worth $109M as of Q1 2026.
Jim Simons sold 395,400 Dr. Reddy's Laboratories shares in Q1 2026, an estimated $5.5M.
Dr. Reddy's Laboratories made up 0.17% of Jim Simons's portfolio in Q1 2026, its #135 holding.
Jim Simons first reported a position in Dr. Reddy's Laboratories in Q3 2013 and has held it in 43 quarters since.
Jim Simons's Dr. Reddy's Laboratories position peaked at $164M in Q3 2020.
248 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.